Aarti Drugs Ltd. | Income Statement
Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
2019
Sales/Revenue
9,699
10,943
11,349
11,952
12,436
15,609
Cost of Goods Sold (COGS) incl. D&A
8,120
9,210
9,604
10,023
10,388
11,635
Gross Income
1,579
1,733
1,745
1,929
2,048
3,975
SG&A Expense
395
334
344
370
409
2,327
EBIT
1,185
1,399
1,401
-
1,639
1,648
Unusual Expense
1
-
35
19
-
-
Non Operating Income/Expense
16
17
10
16
17
62
Interest Expense
335
423
480
400
384
400
Pretax Income
848
997
953
1,160
1,245
1,310
Income Tax
240
225
266
342
422
413
Consolidated Net Income
608
773
687
818
823
898
Net Income
608
773
687
818
823
898
Net Income After Extraordinaries
599
773
687
818
823
898
Net Income Available to Common
608
773
687
818
823
898
EPS (Basic)
25.49
31.90
28.38
34.29
34.90
38.48
Basic Shares Outstanding
24
24
24
24
24
-
EPS (Diluted)
25.48
31.90
28.38
34.29
34.90
-
Diluted Shares Outstanding
24
24
24
24
24
-
EBITDA
1,466
1,709
1,766
1,943
2,039
2,074
Non-Operating Interest Income
13
4
7
5
7
-
About Aarti Drugs
View Profile
